
Roopa Industries Downgraded to Sell Amid Technical Weakness and Fundamental Concerns
2026-09-01 08:28:35Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 31 August 2026. This revision reflects a deterioration in technical indicators alongside mixed financial trends and valuation metrics, prompting a reassessment of the stock’s outlook despite some positive quarterly results.
Read full news article
Roopa Industries Ltd is Rated Sell
2026-08-20 10:10:22Roopa Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 5 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 August 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.
Read full news article
Roopa Industries Downgraded to Sell Amid Mixed Financials and Bearish Technicals
2026-08-06 08:20:13Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 5 August 2026. This change reflects a deterioration in technical indicators despite the company’s very positive quarterly financial performance. Investors are advised to weigh the mixed signals from quality, valuation, financial trends, and technicals before making decisions.
Read full news article
Roopa Industries Ltd Upgraded to Hold as Technicals and Financials Improve
2026-07-29 08:22:57Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 28 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautiously optimistic outlook despite some lingering challenges.
Read full news article
Roopa Industries Downgraded to Sell Amid Mixed Financials and Bearish Technicals
2026-07-21 08:33:37Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 July 2026. This change reflects a complex interplay of deteriorating technical indicators, mixed financial trends, valuation considerations, and quality assessments, signalling caution for investors despite some recent operational improvements.
Read full news article
Roopa Industries Ltd Upgraded to Hold on Improved Technicals and Financial Performance
2026-07-15 08:15:36Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 14 July 2026. This change reflects a notable improvement in the company’s technical indicators, financial results, valuation metrics, and overall quality assessment, signalling a cautious but positive outlook for investors.
Read full news article
Roopa Industries Ltd is Rated Sell
2026-07-08 10:10:04Roopa Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Roopa Industries Downgraded to Sell Amid Mixed Financials and Weak Technicals
2026-06-24 08:16:59Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 23 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, mixed financial trends, valuation considerations, and overall quality assessments, signalling caution for investors despite some recent positive earnings results.
Read full news article
Roopa Industries Ltd Upgraded to Hold on Improved Technicals and Financial Performance
2026-06-17 08:20:01Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 16 June 2026. This change reflects a nuanced improvement across multiple parameters including technical trends, valuation attractiveness, financial performance, and quality metrics, signalling a cautious but positive outlook for investors.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
18-Aug-2026 | Source : BSESubmission of Newspaper Clippings w.r.t publication of Unaudited Financial Results for the 1st Quarter Ended 30th June 2026
Submission Of Unaudited Financial Results
14-Aug-2026 | Source : BSESubmission of Unaudited Financial Results for the quarter ended 30/06/2026
Board Meeting Outcome for Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 14Th August 2026
14-Aug-2026 | Source : BSESubmission of Unaudited financial results and intimation of Outcome of the Board Meeting held on 14th August 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






